Nebraska Cancer Research Center
Lincoln, Nebraska, United States
Social services organization in Lincoln, Nebraska
4600 Valley Rd, Lincoln, NE 68510
About Nebraska Cancer Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
72
SWOG Cancer Research Network
19
Alliance for Clinical Trials in Oncology
16
Bristol-Myers Squibb
11
Novartis Pharmaceuticals
7
ECOG-ACRIN Cancer Research Group
6
Eli Lilly and Company
6
Gilead Sciences
6
Merck Sharp & Dohme LLC
6
Pfizer
6
Seagen Inc.
6
Clinical Trials at Nebraska Cancer Research Center
During the past decade, Nebraska Cancer Research Center conducted 159 clinical trials. In the 10-year time frame, 159 clinical trials started and 107 clinical trials were completed, i.e. on
average, 67.3% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 56 clinical trials were completed. i.e. 96.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
2004-10-26
Active, not recruiting
452
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
2007-08-01
2011-01-01
Completed
109
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nebraska Cancer Research Center" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "SWOG Cancer Research Network" with 19 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "Bristol-Myers Squibb" with 11 trials sponsored and "Novartis Pharmaceuticals"
with 11 trials sponsored. Other sponsors include 143 different institutions and
companies that sponsored additional 93 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nebraska Cancer Research Center"
#1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "Merck Sharp & Dohme LLC" with 13 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator and "Hoosier Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 70 different institutions and companies that were
collaborators in the rest 57 trials.
Clinical Trials Conditions at Nebraska Cancer Research Center
According to Clinical.Site data, the most researched conditions in "Nebraska Cancer Research Center" are
"Breast Cancer" (20 trials), "Melanoma" (14 trials), "Colorectal Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Renal Cell Carcinoma" (9 trials). Many other conditions were trialed in "Nebraska Cancer Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Nebraska Cancer Research Center
Most popular intervention types in "Nebraska Cancer Research Center" are "Drug" (236 trials), "Other" (100 trials), "Biological" (75 trials), "Procedure" (24 trials) and "Radiation" (15 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (34 trials), "Pembrolizumab" (26 trials), "Placebo" (24 trials) and "Nivolumab" (22 trials). Other intervention names were less common.
Clinical Trials Genders at Nebraska Cancer Research Center
The vast majority of trials in "Nebraska Cancer Research Center" are
224 trials for "All" genders, 27 trials for "Female" genders and 22 trials for "Male" genders.
Clinical Trials Status at Nebraska Cancer Research Center
Currently, there are NaN active trials in "Nebraska Cancer Research Center".
undefined are not yet recruiting,
75 are recruiting,
93 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 70 completed trials in Nebraska Cancer Research Center,
2 suspended trials,
and 26 terminated clinical trials to date.
Out of the total trials that were conducted in Nebraska Cancer Research Center, 47 "Phase 1"
clinical trials were conducted, 122 "Phase 2" clinical
trials and 117 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Nebraska Cancer Research Center
Nebraska Cancer Research Center has several departments that took part in Clinical trials: "Nebraska Cancer Specialists,8303 Dodge Street" - 2 trials, "Nebraska Cancer Specialist/Missouri Valley Cancer Consortium" - 2 trials
Departments List